PortalPublikationenNFκB and Kidney Injury

NFκB and Kidney Injury

Standard

NFκB and Kidney Injury. / Song, Ning; Thaiss, Friedrich; Guo, Linlin.

in: FRONT IMMUNOL, Jahrgang 10, 2019, S. 815.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Song, N, Thaiss, F & Guo, L 2019, 'NFκB and Kidney Injury', FRONT IMMUNOL, Jg. 10, S. 815. https://doi.org/10.3389/fimmu.2019.00815

APA

Song, N., Thaiss, F., & Guo, L. (2019). NFκB and Kidney Injury. FRONT IMMUNOL, 10, 815. https://doi.org/10.3389/fimmu.2019.00815

Vancouver

Song N, Thaiss F, Guo L. NFκB and Kidney Injury. FRONT IMMUNOL. 2019;10:815. https://doi.org/10.3389/fimmu.2019.00815

Bibtex

@article{51683b4bbf1942de9fca1a3d7b74243a,
title = "NFκB and Kidney Injury",
abstract = "The global burden of chronic kidney disease will increase during the next century. As NFκB, first described more than 30 years ago, plays a major role in immune and non-immune-mediated diseases and in inflammatory and metabolic disorders, this review article summarizes current knowledge on the role of NFκB in in vivo kidney injury and describes the new and so far not completely understood crosstalk between canonical and non-canonical NFκB pathways in T-lymphocyte activation in renal disease.",
author = "Ning Song and Friedrich Thaiss and Linlin Guo",
year = "2019",
doi = "10.3389/fimmu.2019.00815",
language = "English",
volume = "10",
pages = "815",
journal = "FRONT IMMUNOL",
issn = "1664-3224",
publisher = "Lausanne : Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - NFκB and Kidney Injury

AU - Song, Ning

AU - Thaiss, Friedrich

AU - Guo, Linlin

PY - 2019

Y1 - 2019

N2 - The global burden of chronic kidney disease will increase during the next century. As NFκB, first described more than 30 years ago, plays a major role in immune and non-immune-mediated diseases and in inflammatory and metabolic disorders, this review article summarizes current knowledge on the role of NFκB in in vivo kidney injury and describes the new and so far not completely understood crosstalk between canonical and non-canonical NFκB pathways in T-lymphocyte activation in renal disease.

AB - The global burden of chronic kidney disease will increase during the next century. As NFκB, first described more than 30 years ago, plays a major role in immune and non-immune-mediated diseases and in inflammatory and metabolic disorders, this review article summarizes current knowledge on the role of NFκB in in vivo kidney injury and describes the new and so far not completely understood crosstalk between canonical and non-canonical NFκB pathways in T-lymphocyte activation in renal disease.

U2 - 10.3389/fimmu.2019.00815

DO - 10.3389/fimmu.2019.00815

M3 - SCORING: Review article

C2 - 31040851

VL - 10

SP - 815

JO - FRONT IMMUNOL

JF - FRONT IMMUNOL

SN - 1664-3224

ER -